GT Biopharma Inc(OOTC : OXIS)
(
)
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Message Boards
...
News
...
Health Technology » Pharmaceuticals Other
Company Profile
GT Biopharma, Inc. is engages in the development of immunotherapies for the treatment of cancer. Its product includes medicines like OXS-1550, for Acute lymphoblastic leukemia & Non-Hodgkin's lymphoma, OXS-1650 for Refractory Epithelial Ovarian cancer, OXS-3550 for B-cell malignancies, OXS-4550 for Triple Negative Breast & other TAG-72+ cancers, OXS-1750 for Multiple Myeloma & Secondary Osteolytic Lesions, OXS-1950 for FZD7+ Taxol Refractory Solid Tumors, and OXS-2050 for Triple Negative Breast & other ICAM+ cancers. The company was founded in 1965 and is headquartered in Tampa, FL.